Duncan Gregory Scott 4
4 · Dogwood Therapeutics, Inc. · Filed Jul 1, 2025
Insider Transaction Report
Form 4
Duncan Gregory Scott
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Stock Option (right to buy)
2025-06-27+40,000→ 40,000 totalExercise: $4.71Exp: 2035-06-27→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The stock option vests one-third on June 27, 2026 and 1/24th monthly thereafter.